Related Experiment Video
Updated: Jun 23, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Reduced platelet BDNF level in patients with major depression
1Department of Psychiatry, College of Medicine, Korea University Ansan Hospital, Republic of Korea.
Abstract:
Serum and plasma brain-derived neurotrophic factor (BDNF) levels as well as brain BDNF have previously been shown to be decreased in patients with major depressive disorder (MDD). We explored whether platelet BDNF levels, circulating stored BDNF, would be lower in MDD patients than in normal controls. BDNF levels were examined in platelet-rich plasma (PRP) and platelet-poor plasma (PPP) in 20 hospitalized non-suicidal MDD patients, 20 recent-suicidal MDD patients, and 20 normal controls. Platelet BDNF content was calculated by subtracting PPP BDNF level from PRP BDNF level, and dividing the result by the total platelet count, and it was expressed as pg/10(6) platelets. Individuals were evaluated using a Structured Clinical Interview for DSM-IV and a Hamilton Depression Rating Scale. Platelet BDNF contents were significantly lower in non-suicidal patients (3.09+/-2.53 pg/10(6) platelets) and recent-suicidal MDD patients (3.16+/-1.99 pg/10(6) platelets) than in healthy controls (6.17+/-2.64 pg/10(6) platelets) (p<0.01). However, platelet BDNF contents had no significant differences between non-suicidal and recent-suicidal patients. PRP BDNF levels were also significantly lower in non-suicidal and suicidal MDD patients than in healthy controls (p=0.029), while PPP BDNF had no significant difference between 3 groups (p=0.971). Our findings suggest that there is a decrease in the platelet BDNF of patients with major depression. Reduced platelet BDNF contents as circulating stored BDNF could be associated with lower serum BDNF level in patients with major depression.
Insights
Platelet brain-derived neurotrophic factor (BDNF) levels are significantly lower in patients with major depressive disorder (MDD). This finding suggests reduced platelet BDNF may be linked to lower serum BDNF in depression.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Decreased serum, plasma, and brain brain-derived neurotrophic factor (BDNF) levels are observed in major depressive disorder (MDD).
- Platelets store significant amounts of BDNF, acting as a circulating reservoir.
Purpose of the Study:
- To investigate whether platelet BDNF levels are reduced in patients with MDD compared to healthy controls.
- To explore potential differences in platelet BDNF between non-suicidal and recent-suicidal MDD patients.
Main Methods:
- BDNF levels were measured in platelet-rich plasma (PRP) and platelet-poor plasma (PPP) from 20 non-suicidal MDD patients, 20 recent-suicidal MDD patients, and 20 healthy controls.
- Platelet BDNF content was calculated and standardized per million platelets.
- Participants were assessed using the Structured Clinical Interview for DSM-IV and the Hamilton Depression Rating Scale.
Main Results:
- Platelet BDNF content was significantly lower in both non-suicidal (3.09±2.53 pg/10^6 platelets) and recent-suicidal (3.16±1.99 pg/10^6 platelets) MDD patients compared to healthy controls (6.17±2.64 pg/10^6 platelets) (p<0.01).
- No significant difference in platelet BDNF content was found between non-suicidal and recent-suicidal MDD groups.
- PRP BDNF levels were lower in MDD patients than controls (p=0.029), while PPP BDNF levels showed no significant difference between groups (p=0.971).
Conclusions:
- Platelet BDNF content is significantly reduced in patients with major depressive disorder.
- Reduced platelet BDNF may contribute to lower circulating BDNF levels observed in MDD.
- Platelet BDNF serves as a potential biomarker for major depressive disorder.
Related Concept Videos
Depression: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
G-protein Coupled Receptors
Depressive Disorders: MDD and Dysthymia
